Your browser doesn't support javascript.
loading
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours.
Froeling, Fieke E M; Ramaswami, Ramya; Papanastasopoulos, Panagiotis; Kaur, Baljeet; Sebire, Neil J; Short, Dee; Fisher, Rosemary A; Sarwar, Naveed; Wells, Michael; Singh, Kam; Ellis, Laura; Horsman, Janet M; Winter, Matthew C; Tidy, John; Hancock, Barry W; Seckl, Michael J.
Afiliação
  • Froeling FEM; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Ramaswami R; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Papanastasopoulos P; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Kaur B; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Sebire NJ; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Short D; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Fisher RA; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Sarwar N; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK.
  • Wells M; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Singh K; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Ellis L; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Horsman JM; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Winter MC; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Tidy J; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Hancock BW; Trophoblastic Disease Centre, Weston Park Hospital, Sheffield, UK.
  • Seckl MJ; Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College NHS Healthcare Trust and Imperial College London, London, UK. m.seckl@imperial.ac.uk.
Br J Cancer ; 120(6): 587-594, 2019 03.
Article em En | MEDLINE | ID: mdl-30792530
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Tumor Trofoblástico de Localização Placentária / Neoplasias Trofoblásticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Tumor Trofoblástico de Localização Placentária / Neoplasias Trofoblásticas Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article